A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote the formation of cartilage tissue through controlled drug release.
Background
Cartilage has a limited ability to repair itself due to its avascular nature, which restricts nutrient flow and cell migration. Various scaffold materials, including natural polymers and composites, have been tested for cartilage repair. However, many of these face limitations such as poor mechanical strength, weak cell signaling, and inconsistent drug delivery.
Hydrogels are promising in this context because they are hydrophilic, biodegradable, and can mimic the properties of natural tissue. Designing hydrogels that coordinate immune regulation and tissue regeneration, however, remains a complex challenge.
Dexamethasone is a corticosteroid with strong anti-inflammatory effects. It can shift macrophages toward an M2 phenotype, which supports tissue repair. Kartogenin is a small molecule known to stimulate mesenchymal stem cells (MSCs) to differentiate into chondrocytes, enhancing cartilage formation. Combining both agents in a single hydrogel aims to first reduce inflammation and then encourage cartilage regeneration.
The Current Study
Researchers created a silk fibroin-based nanocomposite hydrogel loaded with Dex and KGN. KGN was covalently linked to silk proteins to form nanospheres (SPNs) that release the drug over time. Dex was incorporated non-covalently via hydrogen bonding with the silk matrix, forming a Dex-HLC complex intended for rapid release.
The hydrogel network was stabilized using enzymatic crosslinking with transglutaminase, which promoted covalent bonding between amino acid residues in the silk fibroin. This structure allowed for staged drug release: Dex would be released early to manage inflammation, and KGN would be released gradually during the tissue regeneration phase.
The hydrogel’s physical and chemical properties—such as strength, degradation rate, and drug release behavior—were assessed through spectroscopy, degradation studies, and release tests. Cytocompatibility was evaluated using cultures of MSCs and macrophages to monitor adhesion, growth, and differentiation.
An in vivo rabbit model of cartilage defect was used to test the hydrogel’s repair performance. After implantation, tissue samples were evaluated through histological staining (H&E, Safranin O), immunohistochemistry for inflammation and cartilage markers, and micro-CT imaging to assess cartilage and bone formation.
Results and Discussion
The hydrogel formed a stable and elastic structure with mechanical properties similar to native cartilage. It degraded at a rate aligned with typical cartilage healing timelines. In early-stage testing, Dex was released quickly and reduced inflammation, as shown by lower levels of cytokines such as TNF-α and IL-6. Macrophage analysis showed a shift from the M1 (inflammatory) to M2 (anti-inflammatory) phenotype after Dex exposure.
KGN was released over a longer period, supporting the differentiation of MSCs into chondrocytes. This was confirmed by increased expression of markers like type II collagen, SOX-9, and aggrecan. At the same time, expression of hypertrophy-associated markers like RUNX2 decreased, while RUNX1 expression increased, indicating stable chondrogenic differentiation and reduced risk of cartilage overgrowth.
In the rabbit model, defects treated with the hydrogel showed significant formation of hyaline-like cartilage, with organized extracellular matrix and tissue structures resembling native cartilage. These regions showed higher levels of cartilage matrix components and new bone formation compared to control groups. Immunohistochemical staining revealed reduced inflammatory signaling and increased collagen type II levels, confirming tissue regeneration with limited inflammation and hypertrophy.
Conclusion
This study describes a dual-drug nanocomposite hydrogel for cartilage repair that delivers Dex for early inflammation control and KGN for long-term cartilage regeneration. The material showed favorable mechanical performance, cell compatibility, and regenerative effects in a rabbit cartilage defect model. The combination of immune modulation and support for chondrogenesis represents a comprehensive strategy for tissue engineering.
While initial results are encouraging, further research is needed to refine drug delivery profiles, evaluate long-term outcomes, and confirm safety in larger animal models. This approach highlights the potential of responsive hydrogel systems in addressing challenges in cartilage repair and osteoarthritis treatment.
Journal Reference
Lei, H., Fan, D. (2025). Dual drug delivery nanocomposite hydrogel for cartilage repair: immunomodulation and chondrogenesis. Engineering. DOI: 10.1016/j.eng.2025.05.010, https://www.sciencedirect.com/science/article/pii/S2095809925002875?via%3Dihub
News
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
